Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma
Open Access
- 2 October 2009
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 137 (4) , 1270-1279
- https://doi.org/10.1053/j.gastro.2009.06.053
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
- National Cancer Institute (CA104683-02, CA15083)
This publication has 62 references indexed in Scilit:
- Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinomaBritish Journal of Cancer, 2008
- Tumor immunoediting and immunosculpting pathways to cancer progressionSeminars in Cancer Biology, 2007
- Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: A potential role for dysregulation of the transforming growth factor-β pathwayEuropean Journal Of Cancer, 2007
- CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal CancerPLOS ONE, 2006
- Attenuation of CD8+ T-Cell Function by CD4+CD25+ Regulatory T Cells in B-Cell Non-Hodgkin's LymphomaCancer Research, 2006
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJournal of Clinical Investigation, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Natural versus adaptive regulatory T cellsNature Reviews Immunology, 2003
- Changes of blood T cell subsets in patients receiving postoperative adjuvant chemotherapy for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984